Torrent Pharma (TRP IN) reported decent performance in Q1FY20, with revenue stood at Rs 2,022Cr (vs estimate of Rs 2,017 Cr), which is largely in-line with our estimate. EBITDA at Rs541Cr (estimate of Rs521Cr) and EBITDA margins stood at 26.8% (expanded by ~127bps QoQ).